These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8590278)

  • 1. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    J Ocul Pharmacol Ther; 1995; 11(3):469-87. PubMed ID: 8590278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iris vasculopathy in galactose-fed rats.
    Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
    Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability changes at blood-retinal barrier in diabetes and effect of aldose reductase inhibition.
    Lightman S; Pinter G; Yuen L; Bradbury M
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R601-5. PubMed ID: 2118733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats.
    Fujii S; Setoguchi C; Kawazu K; Hosoya K
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4650-8. PubMed ID: 24985475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
    Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P
    Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R; Ohrloff C
    Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
    Robison WG; Laver NM; Jacot JL; Chandler ML; York BM; Glover JP
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
    Jacot JL; Hosotani H; Glover JP; Lois N; Robison WG
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):169-80. PubMed ID: 9572543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Neuenschwander H; Takahashi Y; Kador PF
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):517-28. PubMed ID: 9436155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The blood-retina barrier and blood-aqueous humor barrier in type I diabetic patients without retinopathy. Determination of permeability using fluorophotometry and laser flare measurements].
    Schalnus R; Ohrloff C
    Klin Monbl Augenheilkd; 1993 Apr; 202(4):281-7. PubMed ID: 8331884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract]   [Full Text] [Related]  

  • 13. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilocarpine-induced flare is physiological rather than pathological.
    Freddo TF; Neville N; Gong H
    Exp Eye Res; 2013 Feb; 107():37-43. PubMed ID: 23187102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tyndallometry in patients with diabetic macular edema before and after central laser coagulation].
    Wiedemann R; Walter A; Wiedemann P
    Klin Monbl Augenheilkd; 1998 Jan; 212(1):32-6. PubMed ID: 9541892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats.
    Berkowitz BA; Roberts R; Luan H; Peysakhov J; Mao X; Thomas KA
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2391-8. PubMed ID: 15223822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
    Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
    Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
    Navaratna D; McGuire PG; Menicucci G; Das A
    Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of partial vitrectomy on blood-ocular barrier function in the rabbit.
    Garner WH; Scheib S; Berkowitz BA; Suzuki M; Wilson CA; Graff G
    Curr Eye Res; 2001 Nov; 23(5):372-81. PubMed ID: 11910527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.